GB/T 38790.1-2020
ActiveEfficacy evaluation of bioactive peptides—Part 1:General principles
生物活性肽功效评价 第1部分：总则
Application Summary AI generated
This standard establishes the general principles, terminology, and evaluation framework for assessing the efficacy of bioactive peptides. It is applied in the food, pharmaceutical, and nutraceutical industries to guide the design and reporting of in vitro, in vivo, and clinical studies for health claims such as antioxidant, antihypertensive, or immunomodulatory effects. The standard ensures consistency and scientific rigor in efficacy testing across research institutions and product development contexts.
Related Standards
NY/T 702-2003
Hop
NY/T 629-2002
Propolis
NY 626-2002
Shennong synthetic line pig
NY 624-2002
Jun Mu No. 1 white pig
NY 625-2002
Composite line DEKALB breeding pig
NY 623-2002
Inner Mongolia Cashmere Goat
GB/Z 44313-2024
Biotechnology—Biobanking—Requirements for the biobanking of plant biological material for research and development
GB/Z 44314-2024
Biotechnology—Biobanking—Requirements for the biobanking of animal biological material
Transparency note: The application summary and key sentences on this page were automatically generated by AI from the standard's original text. This content has not been human-verified and should not be used for compliance or regulatory purposes. Always refer to the official standard document from the issuing authority.